Who makes CKD-501, D745, D150, D029?

CKD-501, D745, D150, D029 is developed by Chong Kun Dang Pharmaceutical.

What development phase is CKD-501, D745, D150, D029 in?

CKD-501, D745, D150, D029 is in Phase 1.

Last reviewed 2026-04-19 · How we verify

CKD-501, D745, D150, D029

Chong Kun Dang Pharmaceutical · Phase 1 active Small molecule

At a glance

Generic name	CKD-501, D745, D150, D029
Sponsor	Chong Kun Dang Pharmaceutical
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

CKD-501, D745, D150, D029 CI brief — competitive landscape report
CKD-501, D745, D150, D029 updates RSS · CI watch RSS
Chong Kun Dang Pharmaceutical portfolio CI